Edition:
United States

Repros Therapeutics Inc (RPRX.OQ)

RPRX.OQ on NASDAQ Stock Exchange Capital Market

0.66USD
14 Dec 2017
Change (% chg)

$0.00 (+0.32%)
Prev Close
$0.66
Open
$0.66
Day's High
$0.66
Day's Low
$0.66
Volume
119,506
Avg. Vol
220,492
52-wk High
$1.55
52-wk Low
$0.26

Select another date:

BRIEF-Repros Says Received EMA Feedback That Negative Opinion Is Likely To Be Received In Jan 2018

* REPROS THERAPEUTICS INC.® RECEIVES FEEDBACK FOLLOWING AN ORAL EXPLANATION WITH THE EUROPEAN MEDICINES AGENCY

BRIEF-Repros Therapeutics Announces Acquisition By Allergan

* REPROS THERAPEUTICS INC.® ANNOUNCES ACQUISITION BY ALLERGAN PLC

BRIEF-Repros Therapeutics Q3 loss per share $0.04

* Repros Therapeutics Inc.® reports third quarter 2017 financial results

BRIEF-Rosalind Advisors reports 5.7 pct stake in Repros Therapeutics

* Rosalind Advisors Inc reports 5.7 percent passive stake in Repros Therapeutics Inc as of July 20 - SEC filing Source text: (http://bit.ly/2gXOAhU) Further company coverage:

BRIEF-Repros Therapeutics ‍expects to receive European patent ‍​

* Repros Therapeutics Inc - ‍expects to receive European patent that relates to selective progesterone modulators​

Select another date: